HHS Issues RFI to Accelerate AI in Clinical Care

What happened

On December 19, 2025, the U.S. Department of Health and Human Services (HHS) released a Request for Information (RFI) seeking public input on accelerating AI adoption in clinical care. The RFI focuses on regulation, reimbursement, and research, with a stakeholder comment deadline of February 23, 2026. It also references the FDA's December 15, 2025, announcement removing a limitation on real-world evidence.

Why it matters

This policy guidance aims to establish a clear regulatory framework for AI in healthcare, linking reimbursement to value and outcomes. It emphasizes implementation science to translate AI concepts into real-world clinical use, particularly for diabetes technologies like continuous glucose monitoring and automated insulin delivery.